MDB Capital Holdings, LLC (NASDAQ:MDBH) Sees Large Decline in Short Interest

MDB Capital Holdings, LLC (NASDAQ:MDBH) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totaling 4,239 shares, a decline of 31.5% from the March 15th total of 6,192 shares. Based on an average daily volume of 3,339 shares, the days-to-cover ratio is currently 1.3 days. Approximately 0.1% of the company’s shares are short sold.

Institutional Trading of MDB Capital

Several hedge funds have recently added to or reduced their stakes in MDBH. DRW Securities LLC purchased a new position in MDB Capital in the fourth quarter worth approximately $40,000. Citadel Advisors LLC purchased a new stake in shares of MDB Capital during the 3rd quarter worth $43,000. Finally, Raymond James Financial Inc. acquired a new position in shares of MDB Capital during the second quarter worth $27,000. Institutional investors and hedge funds own 0.35% of the company’s stock.

MDB Capital Stock Performance

Shares of MDBH opened at $3.61 on Tuesday. The company’s 50-day simple moving average is $3.10 and its 200-day simple moving average is $3.38. MDB Capital has a 1 year low of $2.75 and a 1 year high of $5.50. The stock has a market capitalization of $37.18 million, a PE ratio of -1.69 and a beta of 0.93.

MDB Capital (NASDAQ:MDBH) last released its earnings results on Tuesday, March 31st. The company reported ($0.18) earnings per share (EPS) for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of MDB Capital in a research report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.